Diversifying the research landscape: Assessing barriers to research for underrepresented populations in an online study of Parkinson's disease

被引:1
|
作者
Sanchez, Angie V. [1 ,2 ]
Ison, Juliana M. [1 ]
Hemley, Helen [1 ]
Jackson, Jonathan D. [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
关键词
Research barriers; Parkinson's disease; underrepresented groups; diverse representation; disparities; health equity; CLINICAL-TRIALS; PARTICIPATION; RECRUITMENT; STRATEGIES; RETENTION; ETHICS;
D O I
10.1017/cts.2024.20
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Despite federal regulations mandating the inclusion of underrepresented groups in research, recruiting diverse participants remains challenging. Identifying and implementing solutions to recruitment barriers in real time might increase the participation of underrepresented groups. Hence, the present study created a comprehensive dashboard of barriers to research participation. Barriers to participation were recorded in real time for prospective participants. Overall, 230 prospective participants expressed interest in the study but were unable to join due to one or more barriers. Awareness of the most common obstacles to research in real time will give researchers valuable data to meaningfully modify recruitment methods.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Parkinson’s disease and translational research
    Elisabeth Dinter
    Theodora Saridaki
    Leonie Diederichs
    Heinz Reichmann
    Björn H. Falkenburger
    Translational Neurodegeneration, 9
  • [23] Parkinson's disease and translational research
    Dinter, Elisabeth
    Saridaki, Theodora
    Diederichs, Leonie
    Reichmann, Heinz
    Falkenburger, Bjoern H.
    TRANSLATIONAL NEURODEGENERATION, 2020, 9 (01)
  • [24] Lack of diversity in Parkinson's disease genetic research: current landscape and future directions
    Schumacher-Schuh, A.
    Bieger, A.
    Strelow, M.
    Okunoye, O.
    Mok, K.
    Ahmad-Annuar, A.
    Bardien, S.
    Lim, S. -Y.
    Rao, S.
    Zewde, Y.
    Dindayal, S.
    Azar, J.
    Lesage, S.
    Mata, I.
    MOVEMENT DISORDERS, 2021, 36 : S321 - S322
  • [25] Disease progression strikingly differs in research and real-world Parkinson's populations
    Beaulieu-Jones, Brett K.
    Frau, Francesca
    Bozzi, Sylvie
    Chandross, Karen J.
    Peterschmitt, M. Judith
    Cohen, Caroline
    Coulovrat, Catherine
    Kumar, Dinesh
    Kruger, Mark J.
    Lipnick, Scott L.
    Fitzsimmons, Lane
    Kohane, Isaac S.
    Scherzer, Clemens R.
    NPJ PARKINSONS DISEASE, 2024, 10 (01)
  • [26] Disease progression strikingly differs in research and real-world Parkinson’s populations
    Brett K. Beaulieu-Jones
    Francesca Frau
    Sylvie Bozzi
    Karen J. Chandross
    M. Judith Peterschmitt
    Caroline Cohen
    Catherine Coulovrat
    Dinesh Kumar
    Mark J. Kruger
    Scott L. Lipnick
    Lane Fitzsimmons
    Isaac S. Kohane
    Clemens R. Scherzer
    npj Parkinson's Disease, 10
  • [27] Comparison of an Online -Only Parkinson's Disease Research Cohort to Cohorts Assessed In Person
    Chahine, Lana M.
    Chin, Iris
    Caspell-Garcia, Chelsea
    Standaert, David G.
    Brown, Ethan
    Smolensky, Luba
    Arnedo, Vanessa
    Daeschler, Daisy
    Riley, Lindsey
    Korell, Monica
    Dobkin, Roseanne
    Amondikar, Ninad
    Gradinscak, Stephen
    Shoulson, Ira
    Dean, Marissa
    Kwok, Kevin
    Cannon, Paul
    Marek, Kenneth
    Kopil, Catherine
    Tanner, Caroline M.
    Marras, Connie
    JOURNAL OF PARKINSONS DISEASE, 2020, 10 (02) : 677 - 691
  • [28] Brainstem avenues in Parkinson's disease research
    Bologna, Matteo
    Berardelli, Alfredo
    CLINICAL NEUROPHYSIOLOGY, 2019, 130 (04) : 554 - 555
  • [29] Research on developing drugs for Parkinson's disease
    Zhang, Cheng-Lu
    Han, Qi-Wen
    Chen, Nai-Hong
    Yuan, Yu-He
    BRAIN RESEARCH BULLETIN, 2021, 168 : 100 - 109
  • [30] Contextualizing stigma in Parkinson's disease research
    de la Rosa, Tom
    Scorza, Fulvio Alexandre
    CLINICS, 2024, 79